EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oral Administration of Lactobacillus acidophilus Expressing GLP-1 Peptide Variants with N-Terminal Extensions in Mice with Streptozotocin-Induced Hyperglycemia

Arthur A Lee iD, Maria B Chernysheva iD, Dmitry A Kashirskikh iD, Evgenii S Ruchko iD, Olesya O Klychkova iD, Victoria A Khotina iD, Tatiana V Noskova, Vagif A Gasanov, Ekaterina A Vorotelyak iD, Andrey V Vasiliev

International Journal of Molecular Sciences · 08.11.2026 · 27 (21) · 10003

DOI: 10.3390/ijms272110003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.11.2026. Verfasst von Arthur A Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, 119334 Moscow, Russia. Hauptthemen laut MEDLINE: Lactobacillus acidophilus, Glucagon-Like Peptide 1, Hyperglycemia, Diabetes Mellitus, Experimental. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Ministry of Education and Science of the Russian Federation, Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Engineered bacteria are being explored as oral delivery systems for therapeutic peptides. This study examined Lactobacillus acidophilus expressing two GLP-1 peptide variants with N-terminal extensions, M-GLP-1 and M-6HIS-GLP-1, in male C57BL/6J mice with moderate streptozotocin (STZ)-induced hyperglycemia. Both purified peptides increased insulin concentrations in MIN6 conditioned medium after 24 h, but neither significantly attenuated the STZ-associated reduction in metabolic activity. Cage-level analysis showed lower average post-treatment glucose concentrations in mice receiving L. acidophilus expressing M-GLP-1 (Lacto-M-GLP-1) or M-6HIS-GLP-1 (Lacto-M-6HIS-GLP-1) than in STZ controls, but neither group differed significantly from mice receiving empty-vector L. acidophilus. The intraperitoneal glucose tolerance test showed numerically lower late-phase glucose concentrations and incremental area under the curve in both groups than in controls. Mice receiving Lacto-M-6HIS-GLP-1 showed greater body-weight change than those receiving Lacto-M-GLP-1 or empty-vector L. acidophilus. Pancreatic histology showed a lower pancreatic glucagon-positive signal area and a higher insulin-to-glucagon signal-area ratio than in STZ controls and Lacto-M-GLP-1. The findings demonstrate cellular responses to purified GLP-1 variants and metabolic changes associated with administering L. acidophilus expressing the peptides.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lactobacillus acidophilusGlucagon-Like Peptide 1HyperglycemiaDiabetes Mellitus, ExperimentalAnimalsMiceMaleAdministration, OralStreptozocinBlood GlucoseInsulinMice, Inbred C57BLGlucose Tolerance Test

Stichwörter der Autor:innen

GLP-1Lactobacillus acidophilusengineered bacteriaglucose tolerancepancreatic isletsstreptozotocin-induced hyperglycemia

Substanzen

Glucagon-Like Peptide 1StreptozocinBlood GlucoseInsulin

Autor:innen und Institutionen

  • Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, 119334 Moscow, Russia.

ORCID-Profile: Arthur A Lee, Maria B Chernysheva, Dmitry A Kashirskikh, Evgenii S Ruchko, Olesya O Klychkova, Victoria A Khotina, Ekaterina A Vorotelyak

Förderung

  • The Ministry of Education and Science of the Russian Federation
  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Lee, A. A., Chernysheva, M. B., Kashirskikh, D. A., Ruchko, E. S., Klychkova, O. O., Khotina, V. A., Noskova, T. V., Gasanov, V. A., Vorotelyak, E. A., & Vasiliev, A. V. (2026). Oral Administration of Lactobacillus acidophilus Expressing GLP-1 Peptide Variants with N-Terminal Extensions in Mice with Streptozotocin-Induced Hyperglycemia. International Journal of Molecular Sciences, 27(21), 10003. https://doi.org/10.3390/ijms272110003

Vancouver

Lee AA, Chernysheva MB, Kashirskikh DA, Ruchko ES, Klychkova OO, Khotina VA, et al. Oral Administration of Lactobacillus acidophilus Expressing GLP-1 Peptide Variants with N-Terminal Extensions in Mice with Streptozotocin-Induced Hyperglycemia. International Journal of Molecular Sciences. 2026;27(21):10003. doi:10.3390/ijms272110003

BibTeX
@article{Lee2026,
  author = {Lee, Arthur A and Chernysheva, Maria B and Kashirskikh, Dmitry A and Ruchko, Evgenii S and Klychkova, Olesya O and Khotina, Victoria A and Noskova, Tatiana V and Gasanov, Vagif A and Vorotelyak, Ekaterina A and Vasiliev, Andrey V},
  title = {Oral Administration of Lactobacillus acidophilus Expressing GLP-1 Peptide Variants with N-Terminal Extensions in Mice with Streptozotocin-Induced Hyperglycemia},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {21},
  pages = {10003},
  doi = {10.3390/ijms272110003}
}
Kostenlos starten →